{"id":4980,"date":"2020-12-09T00:00:00","date_gmt":"2020-12-09T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/12\/09\/over-half-of-obese-patients-have-diabetes-remission-after-rygb\/"},"modified":"2020-12-10T18:10:21","modified_gmt":"2020-12-10T18:10:21","slug":"over-half-of-obese-patients-have-diabetes-remission-after-rygb","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/12\/09\/over-half-of-obese-patients-have-diabetes-remission-after-rygb\/","title":{"rendered":"Over Half of Obese Patients Have Diabetes Remission After RYGB"},"content":{"rendered":"<h3>\n<p>Remission rates greater in younger participants and those with short diabetes duration, higher HOMA percentage B<strong><\/strong><\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, Dec. 9, 2020 (HealthDay News) &#8212; More than half of severely obese patients undergoing Roux-en-Y gastric bypass (RYGB) have diabetes remission, according to a study published online Dec. 3 in the <em>Journal of Clinical Endocrinology &#038; Metabolism<\/em>.<\/p>\n<p>Jonathan Q. Purnell, M.D., from the Oregon Health &#038; Science University in Portland, and colleagues compared diabetes prevalence and remission rates during seven years of follow-up after RYGB and laparoscopic gastric banding (LAGB) in an observational cohort of 2,256 adults with severe obesity at 10 U.S. hospitals.<\/p>\n<p>The researchers found that diabetes remission occurred in 57 percent (46 percent complete; 11 percent partial) and in 22.5 percent (16.9 percent complete; 5.6 percent partial) after RYGB and LAGB, respectively. Remission was greater in younger participants and those with shorter diabetes duration, higher C-peptide levels, higher homeostatic model assessment (HOMA) percentage B (a measure of \u00c3\u009f-cell activity), and lower insulin usage at baseline and with greater postsurgical weight loss following both procedures. Reduced HOMA insulin resistance was associated with a greater likelihood of diabetes remission after LAGB, while after RYGB, increased HOMA percentage B predicted remission. Diabetes remission remained nearly fourfold higher for RYGB versus LAGB after controlling for weight lost.<\/p>\n<p>&#8220;Our large study confirms the importance of weight loss on inducing diabetes remission, but also finds gastric bypass has benefits independent of weight,&#8221; Purnell said in a statement. &#8220;If we can understand what these benefits are, it could lead to new diabetes treatments.&#8221;<\/p>\n<p>One author disclosed financial ties to a medical device company; a second author disclosed ties to a pharmaceutical company.<\/p>\n<p><a href=\"https:\/\/academic.oup.com\/jcem\/advance-article-abstract\/doi\/10.1210\/clinem\/dgaa849\/6006261?redirectedFrom=fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Remission rates greater in younger participants and those with short diabetes duration, higher HOMA percentage B<strong><\/strong><\/p>\n","protected":false},"author":4,"featured_media":5189,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[219,268,257],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/4980"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=4980"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/4980\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/5189"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=4980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=4980"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=4980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}